Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: Characterization and basis of a diagnostic test for MPS

S. Byers, T. Rozaklis, L. K. Brumfield, E. Ranieri, J. J. Hopwood

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

A combination of anion-exchange chromatography and 30-40% gradient polyacrylamide gel electrophoresis (gradient-PAGE) was used to purify and characterize urinary glycosaminoglycans from various mucopolysaccharidoses (MPS). The urinary glycosaminoglycans from the different MPS displayed distinct patterns on gradient-PAGE and further confirmation of MPS types and subtypes was demonstrated by an electrophoretic shift in the banding pattern after digestion with the appropriate MPS enzyme. Thus each of the MPS accumulates a unique spectrum of glycosaminoglycans with a nonreducing terminal consisting of the substrate specific for the deficient enzyme in that particular MPS disorder. The absolute correlation of the nonreducing terminal structure with a particular MPS and the availability of recombinant lysosomal enzymes provide the means for a rapid and accurate diagnosis of individual MPS. Analysis of tissue glycosaminoglycans in one MPS type (feline MPS VI) indicated a tissue-specific pattern of glycosaminoglycan accumulation. Undegraded glycosaminoglycans had distinct banding patterns on gradient-PAGE and although dermatan sulfate was predominantly excreted in MPS VI urine, some tissues were observed to accumulate predominantly chondroitin sulfate glycosaminoglycans, e.g., bone and kidney. The spectrum of glycosaminoglycans excreted in the urine is therefore most likely a combination of glycosaminoglycans from various tissues.

LanguageEnglish
Pages282-290
Number of pages9
JournalMolecular Genetics and Metabolism
Volume65
Issue number4
DOIs
Publication statusPublished - 1 Jan 1998

Keywords

  • Diagnosis
  • Mucopolysaccharidoses
  • Tissue glycosaminoglycans
  • Urinary glycosaminoglycans

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Cite this

Byers, S. ; Rozaklis, T. ; Brumfield, L. K. ; Ranieri, E. ; Hopwood, J. J. / Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses : Characterization and basis of a diagnostic test for MPS. In: Molecular Genetics and Metabolism. 1998 ; Vol. 65, No. 4. pp. 282-290.
@article{cc9f01a64a2043c8a5cec0027495c790,
title = "Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: Characterization and basis of a diagnostic test for MPS",
abstract = "A combination of anion-exchange chromatography and 30-40{\%} gradient polyacrylamide gel electrophoresis (gradient-PAGE) was used to purify and characterize urinary glycosaminoglycans from various mucopolysaccharidoses (MPS). The urinary glycosaminoglycans from the different MPS displayed distinct patterns on gradient-PAGE and further confirmation of MPS types and subtypes was demonstrated by an electrophoretic shift in the banding pattern after digestion with the appropriate MPS enzyme. Thus each of the MPS accumulates a unique spectrum of glycosaminoglycans with a nonreducing terminal consisting of the substrate specific for the deficient enzyme in that particular MPS disorder. The absolute correlation of the nonreducing terminal structure with a particular MPS and the availability of recombinant lysosomal enzymes provide the means for a rapid and accurate diagnosis of individual MPS. Analysis of tissue glycosaminoglycans in one MPS type (feline MPS VI) indicated a tissue-specific pattern of glycosaminoglycan accumulation. Undegraded glycosaminoglycans had distinct banding patterns on gradient-PAGE and although dermatan sulfate was predominantly excreted in MPS VI urine, some tissues were observed to accumulate predominantly chondroitin sulfate glycosaminoglycans, e.g., bone and kidney. The spectrum of glycosaminoglycans excreted in the urine is therefore most likely a combination of glycosaminoglycans from various tissues.",
keywords = "Diagnosis, Mucopolysaccharidoses, Tissue glycosaminoglycans, Urinary glycosaminoglycans",
author = "S. Byers and T. Rozaklis and Brumfield, {L. K.} and E. Ranieri and Hopwood, {J. J.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1006/mgme.1998.2761",
language = "English",
volume = "65",
pages = "282--290",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "4",

}

Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses : Characterization and basis of a diagnostic test for MPS. / Byers, S.; Rozaklis, T.; Brumfield, L. K.; Ranieri, E.; Hopwood, J. J.

In: Molecular Genetics and Metabolism, Vol. 65, No. 4, 01.01.1998, p. 282-290.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses

T2 - Molecular Genetics and Metabolism

AU - Byers, S.

AU - Rozaklis, T.

AU - Brumfield, L. K.

AU - Ranieri, E.

AU - Hopwood, J. J.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - A combination of anion-exchange chromatography and 30-40% gradient polyacrylamide gel electrophoresis (gradient-PAGE) was used to purify and characterize urinary glycosaminoglycans from various mucopolysaccharidoses (MPS). The urinary glycosaminoglycans from the different MPS displayed distinct patterns on gradient-PAGE and further confirmation of MPS types and subtypes was demonstrated by an electrophoretic shift in the banding pattern after digestion with the appropriate MPS enzyme. Thus each of the MPS accumulates a unique spectrum of glycosaminoglycans with a nonreducing terminal consisting of the substrate specific for the deficient enzyme in that particular MPS disorder. The absolute correlation of the nonreducing terminal structure with a particular MPS and the availability of recombinant lysosomal enzymes provide the means for a rapid and accurate diagnosis of individual MPS. Analysis of tissue glycosaminoglycans in one MPS type (feline MPS VI) indicated a tissue-specific pattern of glycosaminoglycan accumulation. Undegraded glycosaminoglycans had distinct banding patterns on gradient-PAGE and although dermatan sulfate was predominantly excreted in MPS VI urine, some tissues were observed to accumulate predominantly chondroitin sulfate glycosaminoglycans, e.g., bone and kidney. The spectrum of glycosaminoglycans excreted in the urine is therefore most likely a combination of glycosaminoglycans from various tissues.

AB - A combination of anion-exchange chromatography and 30-40% gradient polyacrylamide gel electrophoresis (gradient-PAGE) was used to purify and characterize urinary glycosaminoglycans from various mucopolysaccharidoses (MPS). The urinary glycosaminoglycans from the different MPS displayed distinct patterns on gradient-PAGE and further confirmation of MPS types and subtypes was demonstrated by an electrophoretic shift in the banding pattern after digestion with the appropriate MPS enzyme. Thus each of the MPS accumulates a unique spectrum of glycosaminoglycans with a nonreducing terminal consisting of the substrate specific for the deficient enzyme in that particular MPS disorder. The absolute correlation of the nonreducing terminal structure with a particular MPS and the availability of recombinant lysosomal enzymes provide the means for a rapid and accurate diagnosis of individual MPS. Analysis of tissue glycosaminoglycans in one MPS type (feline MPS VI) indicated a tissue-specific pattern of glycosaminoglycan accumulation. Undegraded glycosaminoglycans had distinct banding patterns on gradient-PAGE and although dermatan sulfate was predominantly excreted in MPS VI urine, some tissues were observed to accumulate predominantly chondroitin sulfate glycosaminoglycans, e.g., bone and kidney. The spectrum of glycosaminoglycans excreted in the urine is therefore most likely a combination of glycosaminoglycans from various tissues.

KW - Diagnosis

KW - Mucopolysaccharidoses

KW - Tissue glycosaminoglycans

KW - Urinary glycosaminoglycans

UR - http://www.scopus.com/inward/record.url?scp=0032417009&partnerID=8YFLogxK

U2 - 10.1006/mgme.1998.2761

DO - 10.1006/mgme.1998.2761

M3 - Article

VL - 65

SP - 282

EP - 290

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 4

ER -